1. Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support 
Yago Nieto, Wilbur A Franklin, Roy B Jones, Scott I Berman, Julie Pellom, Anna E Barón, Elizabeth J Shpall 
Biology of Blood and Marrow Transplantation 
Volume 10, Issue 6, Pages (June 2004)
DOI: /j.bbmt

2. Figure 1
Differences in the outcome of OTC+ (n = 16) and OTC− (n = 226) HRPBC patients. A, EFS (P = .007); B, OS (P = .002).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )

3. Figure 2
Differences in the outcome of OTC+ (n = 18) and OTC− (n = 93) MBC patients. A, EFS (P = .04); B, OS (P = .2).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )